Philips North America vs Somerset Therapeutics Private Limited: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Somerset Therapeutics Private Limited.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Somerset Therapeutics Private Limited: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Philips North America — Warning letters0

Somerset Therapeutics Private Limited — Warning letters0

Philips North America — Recalls355

Somerset Therapeutics Private Limited — Recalls0

Philips North America — Approval records0

Somerset Therapeutics Private Limited — Approval records0

Philips North America — Form 483s0

Somerset Therapeutics Private Limited — Form 483s1

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Somerset Therapeutics Private Limited

Most recent FDA action: February 21, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs Somerset Therapeutics Private Limited: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-somerset-therapeutics-private-limited

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗